Court rejects Teva appeal over cholesterol drug Crestor
12/2/2011
A federal appeals court on ascension day refused to revive Teva potion Industries Ltd's patent violation
if (lexico_globals.googleafc.ads.content.length)
{
if (lexico_globals.googleafc.ads.content.length >= 4) {
document.write(lexico_globals.googleafc.ads.contenttop);
document.write(lexico_globals.googleafc.ads.sponsoredlinks);
document.write(l suit against AstraZeneca Pharmaceuticals LP for the rights to Crestor, a multibillion-dollar cholesterol fighter.
More: - Brought to my attention by
Post Comment
Entry 1 of 16100
Last Page | Next Page









